Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 83

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Structural Determinants of Clostridium difficile Toxin A Glucosyltransferase Activity

Pruitt, Rory N., Chumbler, Nicole M., Rutherford, Stacey A., Farrow, Melissa A., Friedman, David B., Spiller, Ben, Lacy, D. Borden · 2012 · Journal of Biological Chemistry

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m111.298414

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Structure of the TcdA GTD. A-C , the UDP-glucose-bound TcdA GTD is shown with the core GT-A family fold in blue and the 𝛂 -helical protrusions from the fold in green . The mobile 516-522 loop is in yellow , and the loop from the apo structure is superimposed on the structure in pink . Ser-517, Trp-519, and UDP-glucose are represented as sticks . B , a close-up view of the 516-522 loop; C , a 'top' view (rotated 90° from the 'front' view shown in A ).
FIGURE 1 Structure of the TcdA GTD. A-C , the UDP-glucose-bound TcdA GTD is shown with the core GT-A family fold in blue and the 𝛂 -helical protrusions from the fold in green . The mobile 516-522 loop is in yellow , and the loop from the apo structure is superimposed on the structure in pink . Ser-517, Trp-519, and UDP-glucose are represented as sticks . B , a close-up view of the 516-522 loop; C , a 'top' view (rotated 90° from the 'front' view shown in A ).CC-BY · From the PDF
FIGURE 2 Comparison of the TcdA and TcdB GTD structures. The structures of the domains are similar in their overall architecture with a root mean square deviation of 1.6 Å for the 𝛂 -carbon backbone. A , the aligned structures of the TcdA ( blue ) and TcdB ( orange ) GTDs are shown as backbone traces . B , a close-up view of the catalytic site with UDP-glucose coordinating residues shown as sticks . UDP-glucose ( light blue ), UDP ( light orange ), and glucose ( light orange ) are also shown as sticks . Manganese ions are shown as small spheres . Although the cores of the GTDs are conserved, the surfaces are highly divergent ( C and D ). The electrostatic surface potentials of the TcdA GTD ( C ) andtheTcdBGTD( D ) are shown with positively charged surfaces colored blue andnegativelychargedsurfacesin red . The coordinated glyconucleosides are shown as yellow sticks .
FIGURE 2 Comparison of the TcdA and TcdB GTD structures. The structures of the domains are similar in their overall architecture with a root mean square deviation of 1.6 Å for the 𝛂 -carbon backbone. A , the aligned structures of the TcdA ( blue ) and TcdB ( orange ) GTDs are shown as backbone traces . B , a close-up view of the catalytic site with UDP-glucose coordinating residues shown as sticks . UDP-glucose ( light blue ), UDP ( light orange ), and glucose ( light orange ) are also shown as sticks . Manganese ions are shown as small spheres . Although the cores of the GTDs are conserved, the surfaces are highly divergent ( C and D ). The electrostatic surface potentials of the TcdA GTD ( C ) andtheTcdBGTD( D ) are shown with positively charged surfaces colored blue andnegativelychargedsurfacesin red . The coordinated glyconucleosides are shown as yellow sticks .CC-BY · From the PDF
FIGURE3 GlucosyltransferaseactivityoftheTcdAandTcdBGTDs. TcdAand TcdBGTDs(0.1nM)weretestedfortheir ability to glucosylate a panel of GTPases (2 𝛍 M) over the course of 1 h using UDP-[ 14 C]glucose (24 𝛍 M) as a co-substrate. Thebandintensitiesfortherepresentativeexperimentsshowninthe insets were quantifiedbydensitometry.Themeans ± S.D.fromthreeindependentreplicates are shown with TcdA in circles andTcdBin triangles . The data are scaled with the average value for Cdc42 modified by TcdA GTD set at 1.
FIGURE3 GlucosyltransferaseactivityoftheTcdAandTcdBGTDs. TcdAand TcdBGTDs(0.1nM)weretestedfortheir ability to glucosylate a panel of GTPases (2 𝛍 M) over the course of 1 h using UDP-[ 14 C]glucose (24 𝛍 M) as a co-substrate. Thebandintensitiesfortherepresentativeexperimentsshowninthe insets were quantifiedbydensitometry.Themeans ± S.D.fromthreeindependentreplicates are shown with TcdA in circles andTcdBin triangles . The data are scaled with the average value for Cdc42 modified by TcdA GTD set at 1.CC-BY · From the PDF
Image 4
CC-BY · From the PDF
FIGURE5 Structure of the TcdA GTD alone and in the context of the TcdA holotoxin structure. A-C , three-dimensional reconstruction of TcdA (32) filtered to 25 Å is shown as a mesh surface with the crystal structure of the TcdA GTD ( blue ) and a model of the TcdA RBD (52) ( green ) placed into the density. UDP-glucose is shown as yellow spheres . In C , the model of the binding domain and the corresponding map density are removed. D , surface of the TcdA GTD showninthesameorientationasin C . The core GT-A fold is shown in blue with the additional 𝛂 -helical regions in green (as in Fig. 1). The 516 -522 loop is colored red , and UDP-glucose is represented as yellow spheres . Amino acids Lys-448, Gln-454, Glu-460, Arg-462, and Gly-471 are shown in purple . The corresponding residues in TcdB have been shown to be involved in substrate binding (45).
FIGURE5 Structure of the TcdA GTD alone and in the context of the TcdA holotoxin structure. A-C , three-dimensional reconstruction of TcdA (32) filtered to 25 Å is shown as a mesh surface with the crystal structure of the TcdA GTD ( blue ) and a model of the TcdA RBD (52) ( green ) placed into the density. UDP-glucose is shown as yellow spheres . In C , the model of the binding domain and the corresponding map density are removed. D , surface of the TcdA GTD showninthesameorientationasin C . The core GT-A fold is shown in blue with the additional 𝛂 -helical regions in green (as in Fig. 1). The 516 -522 loop is colored red , and UDP-glucose is represented as yellow spheres . Amino acids Lys-448, Gln-454, Glu-460, Arg-462, and Gly-471 are shown in purple . The corresponding residues in TcdB have been shown to be involved in substrate binding (45).CC-BY · From the PDF
FIGURE 7 Glucosylation of Rap2A in cells treated with TcdA. A-E , MALDI-TOF/TOF mass spectrometry indicating the glucosylation of the peptide YDPTIEDFYR. A-C , a portion of the MALDI-TOF peptide mass map ( m / z 1013-1825) is shown to highlight the diagnostic singly charged peptide ions at m / z 1318.60 and 1480.65 (labeled in boldface type ) that represent the peptide in the native and glucosylated state, respectively. The m / z 1480.65 is only found in the TcdAtreated samples ( B ). MALDI-TOF/TOF fragmentation spectra are shown for the m / z 1318.60 peptide ( D ) and for the glucosylated m / z 1480.65 form ( E ). Labeled y ions are denoted by cleavage brackets below the sequence. The y8 fragment ion that contains Thr-35 is diagnostic for the modification, which adds 162 Da. Ions are also observed that are consistent with neutral loss of glucose from the y8 and M + Hions.
FIGURE 7 Glucosylation of Rap2A in cells treated with TcdA. A-E , MALDI-TOF/TOF mass spectrometry indicating the glucosylation of the peptide YDPTIEDFYR. A-C , a portion of the MALDI-TOF peptide mass map ( m / z 1013-1825) is shown to highlight the diagnostic singly charged peptide ions at m / z 1318.60 and 1480.65 (labeled in boldface type ) that represent the peptide in the native and glucosylated state, respectively. The m / z 1480.65 is only found in the TcdAtreated samples ( B ). MALDI-TOF/TOF fragmentation spectra are shown for the m / z 1318.60 peptide ( D ) and for the glucosylated m / z 1480.65 form ( E ). Labeled y ions are denoted by cleavage brackets below the sequence. The y8 fragment ion that contains Thr-35 is diagnostic for the modification, which adds 162 Da. Ions are also observed that are consistent with neutral loss of glucose from the y8 and M + Hions.CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 50

  1. Lyras, 2009, Toxin B is essential for virulence of Clostridium difficile, Nature, 458, 1176, 10.1038/nature07822 · DOI · Paper page
  2. Kuehne, 2010, The role of toxin A and toxin B in Clostridium difficile infection, Nature, 467, 711, 10.1038/nature09397 · DOI · Paper page
  3. Hofmann, 1997, Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin, J. Biol. Chem., 272, 11074, 10.1074/jbc.272.17.11074 · DOI · Paper page
  4. Rupnik, 2005, Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells, Microbiology, 151, 199, 10.1099/mic.0.27474-0 · DOI
  5. von Eichel-Streiber, 1990, Clostridium difficile toxin A carries a C-terminal repetitive structure homologous to the carbohydrate binding region of streptococcal glycosyltransferases, Gene, 96, 107, 10.1016/0378-1119(90)90348-U · DOI
  6. Dove, 1990, Molecular characterization of the Clostridium difficile toxin A gene, Infect. Immun., 58, 480, 10.1128/iai.58.2.480-488.1990 · DOI · Paper page
  7. Florin, 1986, Lysosomal involvement in cellular intoxication with Clostridium difficile toxin B, Microb. Pathog., 1, 373, 10.1016/0882-4010(86)90069-0 · doi:10.1016/0882-4010(86)90069-0
  8. Papatheodorou, 2010, Clostridial glucosylating toxins enter cells via clathrin-mediated endocytosis, PLoS One, 5, e10673, 10.1371/journal.pone.0010673 · DOI · Paper page
  9. Giesemann, 2006, Cholesterol-dependent pore formation of Clostridium difficile toxin A, J. Biol. Chem., 281, 10808, 10.1074/jbc.M512720200 · DOI
  10. Barth, 2001, Low pH-induced formation of ion channels by clostridium difficile toxin B in target cells, J. Biol. Chem., 276, 10670, 10.1074/jbc.M009445200 · DOI
  11. Qa'Dan, 2000, pH-induced conformational changes in Clostridium difficile toxin B, Infect. Immun., 68, 2470, 10.1128/IAI.68.5.2470-2474.2000 · DOI
  12. Egerer, 2007, Autocatalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity, J. Biol. Chem., 282, 25314, 10.1074/jbc.M703062200 · DOI · Paper page
  13. Reineke, 2007, Autocatalytic cleavage of Clostridium difficile toxin B, Nature, 446, 415, 10.1038/nature05622 · DOI · Paper page
  14. Just, 1995, Glucosylation of Rho proteins by Clostridium difficile toxin B, Nature, 375, 500, 10.1038/375500a0 · DOI · Paper page
  15. Just, 1995, The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins, J. Biol. Chem., 270, 13932, 10.1074/jbc.270.23.13932 · DOI · Paper page
  16. Jank, 2007, Rho-glucosylating Clostridium difficile toxins A and B. New insights into structure and function, Glycobiology, 17, 15R, 10.1093/glycob/cwm004 · DOI · Paper page
  17. Genth, 2008, Clostridium difficile toxins. More than mere inhibitors of Rho proteins, Int. J. Biochem. Cell Biol., 40, 592, 10.1016/j.biocel.2007.12.014 · DOI
  18. Schirmer, 2004, Large clostridial cytotoxins. Cellular biology of Rho/Ras-glucosylating toxins, Biochim. Biophys. Acta, 1673, 66, 10.1016/j.bbagen.2004.03.014 · DOI
  19. Savidge, 2003, Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine, Gastroenterology, 125, 413, 10.1016/S0016-5085(03)00902-8 · DOI · Paper page
  20. Mitchell, 1986, Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon, Gut, 27, 78, 10.1136/gut.27.1.78 · DOI
  21. Lyerly, 1985, Effects of Clostridium difficile toxins given intragastrically to animals, Infect. Immun., 47, 349, 10.1128/iai.47.2.349-352.1985 · DOI · Paper page
  22. Lyerly, 1992, Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile, Infect. Immun., 60, 4633, 10.1128/iai.60.11.4633-4639.1992 · doi:10.1128/iai.60.11.4633-4639.1992
  23. Giannasca, 2004, Active and passive immunization against Clostridium difficile diarrhea and colitis, Vaccine, 22, 848, 10.1016/j.vaccine.2003.11.030 · DOI
  24. Babcock, 2006, Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters, Infect. Immun., 74, 6339, 10.1128/IAI.00982-06 · DOI · Paper page
  25. Riegler, 1995, Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro, J. Clin. Invest., 95, 2004, 10.1172/JCI117885 · DOI · Paper page
  26. Chaves-Olarte, 1997, Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells, J. Clin. Invest., 100, 1734, 10.1172/JCI119698 · DOI
  27. Sullivan, 1982, Purification and characterization of toxins A and B of Clostridium difficile, Infect. Immun., 35, 1032, 10.1128/iai.35.3.1032-1040.1982 · DOI · Paper page
  28. Kreimeyer, 2011, Autoproteolytic cleavage mediates cytotoxicity of Clostridium difficile toxin A, Naunyn Schmiedebergs Arch. Pharmacol., 383, 253, 10.1007/s00210-010-0574-x · DOI
  29. Krivan, 1986, Cell surface binding site for Clostridium difficile enterotoxin. Evidence for a glycoconjugate containing the sequence Gal α 1–3Gal β 1–4GlcNAc, Infect. Immun., 53, 573, 10.1128/iai.53.3.573-581.1986 · DOI · Paper page
  30. Dingle, 2008, Functional properties of the carboxyl-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile, Glycobiology, 18, 698, 10.1093/glycob/cwn048 · DOI
  31. Frisch, 2003, The complete receptor-binding domain of Clostridium difficile toxin A is required for endocytosis, Biochem. Biophys. Res. Commun., 300, 706, 10.1016/S0006-291X(02)02919-4 · doi:10.1016/s0006-291x(02)02919-4
  32. Pruitt, 2010, Structural organization of the functional domains of Clostridium difficile toxins A and B, Proc. Natl. Acad. Sci. U.S.A., 107, 13467, 10.1073/pnas.1002199107 · DOI
  33. Worby, 2009, The fic domain. Regulation of cell signaling by adenylylation, Mol. Cell., 34, 93, 10.1016/j.molcel.2009.03.008 · DOI · Paper page
  34. de Rooij, 1998, Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP, Nature, 396, 474, 10.1038/24884 · DOI · Paper page
  35. Otwinowski, 1997, Processing of x-ray diffraction data collected in oscillation mode, Methods Enzymol., 276, 307, 10.1016/S0076-6879(97)76066-X · DOI · Paper page
  36. Emsley, 2004, Coot. Model-building tools for molecular graphics, Acta Crystallogr. D Biol. Crystallogr., 60, 2126, 10.1107/S0907444904019158 · DOI · Paper page
  37. Morris, 1992, Stereochemical quality of protein structure coordinates, Proteins, 12, 345, 10.1002/prot.340120407 · DOI · Paper page
  38. Reinert, 2005, Structural basis for the function of Clostridium difficile toxin B, J. Mol. Biol., 351, 973, 10.1016/j.jmb.2005.06.071 · DOI · Paper page
  39. Geissler, 2010, Identification of a conserved membrane localization domain within numerous large bacterial protein toxins, Proc. Natl. Acad. Sci. U.S.A., 107, 5581, 10.1073/pnas.0908700107 · DOI
  40. Mesmin, 2004, A phosphatidylserine-binding site in the cytosolic fragment of Clostridium sordellii lethal toxin facilitates glucosylation of membrane-bound Rac and is required for cytotoxicity, J. Biol. Chem., 279, 49876, 10.1074/jbc.M406903200 · doi:10.1074/jbc.m406903200
  41. Ziegler, 2008, Conformational changes and reaction of clostridial glycosylating toxins, J. Mol. Biol., 377, 1346, 10.1016/j.jmb.2007.12.065 · DOI
  42. Qasba, 2005, Substrate-induced conformational changes in glycosyltransferases, Trends Biochem. Sci., 30, 53, 10.1016/j.tibs.2004.11.005 · DOI · Paper page
  43. Ciesla, 1998, Clostridium difficile toxins A and B are cation-dependent UDP-glucose hydrolases with differing catalytic activities, J. Biol. Chem., 273, 16021, 10.1074/jbc.273.26.16021 · DOI
  44. Jank, 2007, Clostridium difficile glucosyltransferase toxin B-essential amino acids for substrate binding, J. Biol. Chem., 282, 35222, 10.1074/jbc.M703138200 · DOI
  45. Pfeifer, 2003, Cellular uptake of Clostridium difficile toxin B. Translocation of the N-terminal catalytic domain into the cytosol of eukaryotic cells, J. Biol. Chem., 278, 44535, 10.1074/jbc.M307540200 · DOI
  46. Spyres, 2003, Mutational analysis of the enzymatic domain of Clostridium difficile toxin B reveals novel inhibitors of the wild-type toxin, Infect. Immun., 71, 3294, 10.1128/IAI.71.6.3294-3301.2003 · doi:10.1128/iai.71.6.3294-3301.2003
  47. Raaijmakers, 2009, Specificity in Ras and Rap signaling, J. Biol. Chem., 284, 10995, 10.1074/jbc.R800061200 · DOI · Paper page
  48. Huelsenbeck, 2007, Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470, Infect. Immun., 75, 801, 10.1128/IAI.01705-06 · doi:10.1128/iai.01705-06
  49. Chaves-Olarte, 1999, A novel cytotoxin from Clostridium difficile serogroup F is a functional hybrid between two other large clostridial cytotoxins, J. Biol. Chem., 274, 11046, 10.1074/jbc.274.16.11046 · doi:10.1074/jbc.274.16.11046
  50. Ho, 2005, Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A, Proc. Natl. Acad. Sci. U.S.A., 102, 18373, 10.1073/pnas.0506391102 · doi:10.1073/pnas.0506391102

Cited by

Metadata

Authors
Pruitt, R. N., Chumbler, N. M., Rutherford, S. A., Farrow, M. A., Friedman, D. B., Spiller, B., & Lacy, D. B.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2012-03
Volume
287
Issue
11
Pages
8013-8020
ISSN
0021-9258
Cited by
83
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.